Global Vaccine Technologies Market Growth (Status and Outlook) 2025-2031

September 2025 | 92 pages | ID: GD33BE58994EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to this study, the global Vaccine Technologies market size will reach US$ 72820 million by 2031.

Vaccine technologies have been in development since the initial use of killed viral and killed bacterial vaccines.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Vaccine Technologies Industry Forecast” looks at past sales and reviews total world Vaccine Technologies sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccine Technologies sales for 2025 through 2031. With Vaccine Technologies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine Technologies industry.

This Insight Report provides a comprehensive analysis of the global Vaccine Technologies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Vaccine Technologies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine Technologies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine Technologies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine Technologies.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Technologies market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Infection
  • Allergy
  • Cancer
Segmentation by Application:
  • Humans
  • Animals
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Abbott
  • Pfizer
  • Bayer
  • GE Healthcare
  • Glaxosmithkline
  • Johnson and Johnson
  • Thermo Fisher Scientific
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Vaccine Technologies Market Size (2020-2031)
  2.1.2 Vaccine Technologies Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Vaccine Technologies by Country/Region (2020, 2024 & 2031)
2.2 Vaccine Technologies Segment by Type
  2.2.1 Infection
  2.2.2 Allergy
  2.2.3 Cancer
2.3 Vaccine Technologies Market Size by Type
  2.3.1 Vaccine Technologies Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Vaccine Technologies Market Size Market Share by Type (2020-2025)
2.4 Vaccine Technologies Segment by Application
  2.4.1 Humans
  2.4.2 Animals
2.5 Vaccine Technologies Market Size by Application
  2.5.1 Vaccine Technologies Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Vaccine Technologies Market Size Market Share by Application (2020-2025)

3 VACCINE TECHNOLOGIES MARKET SIZE BY PLAYER

3.1 Vaccine Technologies Market Size Market Share by Player
  3.1.1 Global Vaccine Technologies Revenue by Player (2020-2025)
  3.1.2 Global Vaccine Technologies Revenue Market Share by Player (2020-2025)
3.2 Global Vaccine Technologies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 VACCINE TECHNOLOGIES BY REGION

4.1 Vaccine Technologies Market Size by Region (2020-2025)
4.2 Global Vaccine Technologies Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccine Technologies Market Size Growth (2020-2025)
4.4 APAC Vaccine Technologies Market Size Growth (2020-2025)
4.5 Europe Vaccine Technologies Market Size Growth (2020-2025)
4.6 Middle East & Africa Vaccine Technologies Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Vaccine Technologies Market Size by Country (2020-2025)
5.2 Americas Vaccine Technologies Market Size by Type (2020-2025)
5.3 Americas Vaccine Technologies Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Vaccine Technologies Market Size by Region (2020-2025)
6.2 APAC Vaccine Technologies Market Size by Type (2020-2025)
6.3 APAC Vaccine Technologies Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Vaccine Technologies Market Size by Country (2020-2025)
7.2 Europe Vaccine Technologies Market Size by Type (2020-2025)
7.3 Europe Vaccine Technologies Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Vaccine Technologies by Region (2020-2025)
8.2 Middle East & Africa Vaccine Technologies Market Size by Type (2020-2025)
8.3 Middle East & Africa Vaccine Technologies Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL VACCINE TECHNOLOGIES MARKET FORECAST

10.1 Global Vaccine Technologies Forecast by Region (2026-2031)
  10.1.1 Global Vaccine Technologies Forecast by Region (2026-2031)
  10.1.2 Americas Vaccine Technologies Forecast
  10.1.3 APAC Vaccine Technologies Forecast
  10.1.4 Europe Vaccine Technologies Forecast
  10.1.5 Middle East & Africa Vaccine Technologies Forecast
10.2 Americas Vaccine Technologies Forecast by Country (2026-2031)
  10.2.1 United States Market Vaccine Technologies Forecast
  10.2.2 Canada Market Vaccine Technologies Forecast
  10.2.3 Mexico Market Vaccine Technologies Forecast
  10.2.4 Brazil Market Vaccine Technologies Forecast
10.3 APAC Vaccine Technologies Forecast by Region (2026-2031)
  10.3.1 China Vaccine Technologies Market Forecast
  10.3.2 Japan Market Vaccine Technologies Forecast
  10.3.3 Korea Market Vaccine Technologies Forecast
  10.3.4 Southeast Asia Market Vaccine Technologies Forecast
  10.3.5 India Market Vaccine Technologies Forecast
  10.3.6 Australia Market Vaccine Technologies Forecast
10.4 Europe Vaccine Technologies Forecast by Country (2026-2031)
  10.4.1 Germany Market Vaccine Technologies Forecast
  10.4.2 France Market Vaccine Technologies Forecast
  10.4.3 UK Market Vaccine Technologies Forecast
  10.4.4 Italy Market Vaccine Technologies Forecast
  10.4.5 Russia Market Vaccine Technologies Forecast
10.5 Middle East & Africa Vaccine Technologies Forecast by Region (2026-2031)
  10.5.1 Egypt Market Vaccine Technologies Forecast
  10.5.2 South Africa Market Vaccine Technologies Forecast
  10.5.3 Israel Market Vaccine Technologies Forecast
  10.5.4 Turkey Market Vaccine Technologies Forecast
10.6 Global Vaccine Technologies Forecast by Type (2026-2031)
10.7 Global Vaccine Technologies Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Vaccine Technologies Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbott
  11.1.1 Abbott Company Information
  11.1.2 Abbott Vaccine Technologies Product Offered
  11.1.3 Abbott Vaccine Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abbott Main Business Overview
  11.1.5 Abbott Latest Developments
11.2 Pfizer
  11.2.1 Pfizer Company Information
  11.2.2 Pfizer Vaccine Technologies Product Offered
  11.2.3 Pfizer Vaccine Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Pfizer Main Business Overview
  11.2.5 Pfizer Latest Developments
11.3 Bayer
  11.3.1 Bayer Company Information
  11.3.2 Bayer Vaccine Technologies Product Offered
  11.3.3 Bayer Vaccine Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bayer Main Business Overview
  11.3.5 Bayer Latest Developments
11.4 GE Healthcare
  11.4.1 GE Healthcare Company Information
  11.4.2 GE Healthcare Vaccine Technologies Product Offered
  11.4.3 GE Healthcare Vaccine Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 GE Healthcare Main Business Overview
  11.4.5 GE Healthcare Latest Developments
11.5 Glaxosmithkline
  11.5.1 Glaxosmithkline Company Information
  11.5.2 Glaxosmithkline Vaccine Technologies Product Offered
  11.5.3 Glaxosmithkline Vaccine Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Glaxosmithkline Main Business Overview
  11.5.5 Glaxosmithkline Latest Developments
11.6 Johnson and Johnson
  11.6.1 Johnson and Johnson Company Information
  11.6.2 Johnson and Johnson Vaccine Technologies Product Offered
  11.6.3 Johnson and Johnson Vaccine Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Johnson and Johnson Main Business Overview
  11.6.5 Johnson and Johnson Latest Developments
11.7 Thermo Fisher Scientific
  11.7.1 Thermo Fisher Scientific Company Information
  11.7.2 Thermo Fisher Scientific Vaccine Technologies Product Offered
  11.7.3 Thermo Fisher Scientific Vaccine Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Thermo Fisher Scientific Main Business Overview
  11.7.5 Thermo Fisher Scientific Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Vaccine Technologies Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Vaccine Technologies Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Infection
Table 4. Major Players of Allergy
Table 5. Major Players of Cancer
Table 6. Vaccine Technologies Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Vaccine Technologies Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Vaccine Technologies Market Size Market Share by Type (2020-2025)
Table 9. Vaccine Technologies Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Vaccine Technologies Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Vaccine Technologies Market Size Market Share by Application (2020-2025)
Table 12. Global Vaccine Technologies Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Vaccine Technologies Revenue Market Share by Player (2020-2025)
Table 14. Vaccine Technologies Key Players Head office and Products Offered
Table 15. Vaccine Technologies Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Vaccine Technologies Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Vaccine Technologies Market Size Market Share by Region (2020-2025)
Table 20. Global Vaccine Technologies Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Vaccine Technologies Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Vaccine Technologies Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Vaccine Technologies Market Size Market Share by Country (2020-2025)
Table 24. Americas Vaccine Technologies Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Vaccine Technologies Market Size Market Share by Type (2020-2025)
Table 26. Americas Vaccine Technologies Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Vaccine Technologies Market Size Market Share by Application (2020-2025)
Table 28. APAC Vaccine Technologies Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Vaccine Technologies Market Size Market Share by Region (2020-2025)
Table 30. APAC Vaccine Technologies Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Vaccine Technologies Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Vaccine Technologies Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Vaccine Technologies Market Size Market Share by Country (2020-2025)
Table 34. Europe Vaccine Technologies Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Vaccine Technologies Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Vaccine Technologies Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Vaccine Technologies Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Vaccine Technologies Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Vaccine Technologies
Table 40. Key Market Challenges & Risks of Vaccine Technologies
Table 41. Key Industry Trends of Vaccine Technologies
Table 42. Global Vaccine Technologies Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Vaccine Technologies Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Vaccine Technologies Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Vaccine Technologies Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Abbott Details, Company Type, Vaccine Technologies Area Served and Its Competitors
Table 47. Abbott Vaccine Technologies Product Offered
Table 48. Abbott Vaccine Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Abbott Main Business
Table 50. Abbott Latest Developments
Table 51. Pfizer Details, Company Type, Vaccine Technologies Area Served and Its Competitors
Table 52. Pfizer Vaccine Technologies Product Offered
Table 53. Pfizer Vaccine Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Bayer Details, Company Type, Vaccine Technologies Area Served and Its Competitors
Table 57. Bayer Vaccine Technologies Product Offered
Table 58. Bayer Vaccine Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Bayer Main Business
Table 60. Bayer Latest Developments
Table 61. GE Healthcare Details, Company Type, Vaccine Technologies Area Served and Its Competitors
Table 62. GE Healthcare Vaccine Technologies Product Offered
Table 63. GE Healthcare Vaccine Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. GE Healthcare Main Business
Table 65. GE Healthcare Latest Developments
Table 66. Glaxosmithkline Details, Company Type, Vaccine Technologies Area Served and Its Competitors
Table 67. Glaxosmithkline Vaccine Technologies Product Offered
Table 68. Glaxosmithkline Vaccine Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Glaxosmithkline Main Business
Table 70. Glaxosmithkline Latest Developments
Table 71. Johnson and Johnson Details, Company Type, Vaccine Technologies Area Served and Its Competitors
Table 72. Johnson and Johnson Vaccine Technologies Product Offered
Table 73. Johnson and Johnson Vaccine Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Johnson and Johnson Main Business
Table 75. Johnson and Johnson Latest Developments
Table 76. Thermo Fisher Scientific Details, Company Type, Vaccine Technologies Area Served and Its Competitors
Table 77. Thermo Fisher Scientific Vaccine Technologies Product Offered
Table 78. Thermo Fisher Scientific Vaccine Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Thermo Fisher Scientific Main Business
Table 80. Thermo Fisher Scientific Latest Developments

LIST OF FIGURES

Figure 1. Vaccine Technologies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaccine Technologies Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Vaccine Technologies Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Vaccine Technologies Sales Market Share by Country/Region (2024)
Figure 8. Vaccine Technologies Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Vaccine Technologies Market Size Market Share by Type in 2024
Figure 10. Vaccine Technologies in Humans
Figure 11. Global Vaccine Technologies Market: Humans (2020-2025) & ($ millions)
Figure 12. Vaccine Technologies in Animals
Figure 13. Global Vaccine Technologies Market: Animals (2020-2025) & ($ millions)
Figure 14. Global Vaccine Technologies Market Size Market Share by Application in 2024
Figure 15. Global Vaccine Technologies Revenue Market Share by Player in 2024
Figure 16. Global Vaccine Technologies Market Size Market Share by Region (2020-2025)
Figure 17. Americas Vaccine Technologies Market Size 2020-2025 ($ millions)
Figure 18. APAC Vaccine Technologies Market Size 2020-2025 ($ millions)
Figure 19. Europe Vaccine Technologies Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Vaccine Technologies Market Size 2020-2025 ($ millions)
Figure 21. Americas Vaccine Technologies Value Market Share by Country in 2024
Figure 22. United States Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Vaccine Technologies Market Size Market Share by Region in 2024
Figure 27. APAC Vaccine Technologies Market Size Market Share by Type (2020-2025)
Figure 28. APAC Vaccine Technologies Market Size Market Share by Application (2020-2025)
Figure 29. China Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 33. India Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Vaccine Technologies Market Size Market Share by Country in 2024
Figure 36. Europe Vaccine Technologies Market Size Market Share by Type (2020-2025)
Figure 37. Europe Vaccine Technologies Market Size Market Share by Application (2020-2025)
Figure 38. Germany Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 39. France Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Vaccine Technologies Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Vaccine Technologies Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Vaccine Technologies Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Vaccine Technologies Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 52. APAC Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 53. Europe Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 55. United States Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 56. Canada Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 57. Mexico Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 58. Brazil Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 59. China Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 60. Japan Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 61. Korea Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 63. India Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 64. Australia Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 65. Germany Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 66. France Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 67. UK Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 68. Italy Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 69. Russia Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 70. Egypt Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 71. South Africa Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 72. Israel Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 73. Turkey Vaccine Technologies Market Size 2026-2031 ($ millions)
Figure 74. Global Vaccine Technologies Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Vaccine Technologies Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Vaccine Technologies Market Size 2026-2031 ($ millions)